CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading compound profile…

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Cannabinoids/Cannabidivarin

Plant cannabinoids

Cannabidivarin

Definition: CHEBI:182159 · Chemical Entities of Biological Interest · release 253

2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diolCannabidivarinCBDV

45public articles

4registered condition areas

All documents →

Identity & provenance

Chemical identity

C19H26O2 · molecular weight 286.415

CAS: cas:24274-48-4↗CHEBI: CHEBI:182159↗CHEMSPIDER: chemspider:9776426↗DRUGBANK: drugbank:DB14050↗KEGG.COMPOUND: kegg.compound:C20217↗

Sources: ChEBI · 253

0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.

Research areas

Conditions found alongside this compound

Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.

Epilepsy and cannabinoids

7 matching public articles

Candidate association · not a treatment claim

Chronic pain and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Multiple sclerosis and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Parkinson disease and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Linked local records

Medicines and registered studies

Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.

Medicines with this active ingredient

No public medicine record matched.

Registered studies

7 exact source-intervention matches.

Results postedTERMINATED

Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)

CBDV Compound

Protocol onlyRECRUITING

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Cannabidivarin

Protocol onlyCOMPLETED

Shifting Brain Excitation-Inhibition Balance Through the Endocannabinoid System in Men With Autism Spectrum Disorder (ASD) and in Healthy Controls

CBDV

Protocol onlyCOMPLETED

A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.

GWP42006

Protocol onlyCOMPLETED

A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.

GWP42006

Protocol onlyTERMINATED

Safety and Tolerability of GWP42006 in Children and Young Adults With Autism Spectrum Disorder

GWP42006

Protocol onlyUNKNOWN

Androgenetic Alopecia Treatment Using Varin and Cannabidiol-rich Topical Hemp Oil - A Case Series

Latest documents

Recent research

2026

Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Drugs · Free full text · non-commercial reuse

2026

Integrative network analysis reveals organizational principles of the endocannabinoid system.

Journal of Cannabis Research · Free full text

2025

Evaluation of the Profile of Selected Bioactive Compounds and the Potential of Barley Wort Enriched with Malted and Unmalted Hemp Seeds for Brewing Applications.

Molecules · Free full text

2025

Uncovering the antifungal potential of Cannabidiol and Cannabidivarin.

PLOS Neglected Tropical Diseases · Free full text

2025

Potency Analysis of Semi-Synthetic Cannabinoids in Vaping Oils Using Liquid Chromatography Diode Array Detector with Electrospray Ionization Time-of-Flight Mass Spectrometry for Confirmation of Analyte Identity.

Molecules · Free full text

2025

The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia.

Journal of Psychopharmacology (Oxford, England) · Free full text

2025

Molecular targets of cannabinoids and their derivatives in epilepsy - a review with focus on CBD.

Ontology definitions normalize terms; they do not establish medical claims.

Hemp Oil

Acta Biochimica Polonica · Free full text

2025

Effect of cannabinoids on glutamate levels in the human brain: a systematic review and meta-analysis.

Journal of Cannabis Research · Free full text

2024

Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells.

Archives of Toxicology · Free full text

2024

Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma.

Biofactors (Oxford, England) · Free full text

2024

Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain.

The Journal of Pharmacology and Experimental Therapeutics · Free full text · non-commercial reuse

2024

Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells.

Archives of Toxicology · Free full text